Mouse Anti-ATF5 Recombinant Antibody (4G5) (CBMAB-A0568-LY)

Mouse

Human

4G5

IgG2a, κ

WB, ELISA, IHC-P

ATF5 (AAH05174.1, 101 a.a. ~ 200 a.a) partial recombinant protein with GST tag.

Human

IgG2a, κ

Monoclonal

The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Application	Note
IHC-P	3 µg/ml

Liquid

PBS, pH 7.4

None

Batch dependent

> 95% Purity determined by SDS-PAGE.

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.

Activating Transcription Factor 5

ATFX; FLJ34666; HMFN0395

Transcription factor that either stimulates or represses gene transcription through binding of different DNA regulatory elements such as cAMP response element (CRE) (consensus: 5'-GTGACGT[AC][AG]-3'), ATF5-specific response element (ARE) (consensus: 5'-C[CT]TCT[CT]CCTT[AT]-3') but also the amino acid response element (AARE), present in many viral and cellular promoters. Critically involved, often in a cell type-dependent manner, in cell survival, proliferation, and differentiation (PubMed:10373550, PubMed:15358120, PubMed:21212266, PubMed:20654631).
Its transcriptional activity is enhanced by CCND3 and slightly inhibited by CDK4 (PubMed:15358120).
Important regulator of the cerebral cortex formation, functions in cerebral cortical neuroprogenitor cells to maintain proliferation and to block differentiation into neurons. Must be down-regulated in order for such cells to exit the cycle and differentiate (By similarity).
Participates in the pathways by which SHH promotes cerebellar granule neuron progenitor cells proliferation (By similarity).
Critical for survival of mature olfactory sensory neurons (OSN), directs expression of OSN-specific genes (By similarity).
May be involved in osteogenic differentiation (PubMed:22442021).
Promotes cell proliferation and survival by inducing the expression of EGR1 sinergistically with ELK1. Once acetylated by EP300, binds to ARE sequences on target genes promoters, such as BCL2 and EGR1 (PubMed:21791614).
Plays an anti-apoptotic role through the transcriptional regulation of BCL2, this function seems to be cell type-dependent (By similarity).
Cooperates with NR1I3/CAR in the transcriptional activation of CYP2B6 in liver (PubMed:18332083).
In hepatic cells, represses CRE-dependent transcription and inhibits proliferation by blocking at G2/M phase (PubMed:22528486, PubMed:18701499).
May act as a negative regulator of IL1B transduction pathway in liver (PubMed:24379400).
Upon IL1B stimulus, cooperates with NLK to activate the transactivation activity of C/EBP subfamily members (PubMed:25512613).
Besides its function of transcription factor, acts as a cofactor of CEBPB to activate CEBPA and promote adipocyte differentiation (PubMed:24216764).
Regulates centrosome dynamics in a cell-cycle- and centriole-age-dependent manner. Forms 9-foci symmetrical ring scaffold around the mother centriole to control centrosome function and the interaction between centrioles and pericentriolar material (PubMed:26213385).

Cerebellar granule cell precursor proliferation Source: UniProtKB
Circadian rhythm Source: Ensembl
Fat cell differentiation Source: UniProtKB
Multicellular organism growth Source: Ensembl
Negative regulation of apoptotic process Source: UniProtKB
Negative regulation of cell cycle G2/M phase transition Source: UniProtKB
Negative regulation of cell population proliferation Source: UniProtKB
Negative regulation of transcription, DNA-templated Source: UniProtKB
Olfactory bulb interneuron development Source: Ensembl
Positive regulation of transcription, DNA-templated Source: UniProtKB
Positive regulation of transcription by RNA polymerase II Source: NTNU_SB
Post-embryonic development Source: Ensembl
Regulation of centrosome cycle Source: UniProtKB
Regulation of transcription, DNA-templated Source: UniProtKB
Regulation of transcription by RNA polymerase II Source: GO_Central

Centrosome; Nucleus; Cytoplasm. Actively transported to the centrosome and accumulated in the pericentriolar material (PCM) during G1 to M phase via a microtubule-dependent mechanism. During late telophase and cytokinesis, translocates from the centrosome to the midbody.

Ubiquitinated by CDC34 and UBE2B in order to be degraded by the proteasome. Cisplatin inhibits ubiquitination and proteasome-mediated degradation by inhibiting the interaction with CDC34 (PubMed:18458088). Ubiquitination and degradation by the proteasome are inhibited by NLK in a kinase-independent manner (PubMed:25512613).
Phosphorylated by NLK, probably at Ser-92, Thr-94, Ser-126 and Ser-190.
Acetylated at Lys-29 by EP300, the acetylation enhances the interaction with CEBPB, DNA-binding and transactivation activity.